Recombinant Human Envelop VLP Control
Beta LifeScience
SKU/CAT #: BLK-00983P-100UG
The purity of Human Envelop VLP Control is greater than 95% as determined by SEC-HPLC.
Recombinant Human Envelop VLP Control
Beta LifeScience
SKU/CAT #: BLK-00983P-100UG
Collections: Recombinant proteins, Virus-like particle (vlp) proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human Envelop VLP Control is expressed from HEK293. |
Purity | > 95% as determined by HPLC |
Target Symbol | Envelop VLP Control |
Synonyms | Gag polyprotein; Pr55Gag; MA; CA; SP1; p2; nc; SP2; p1; p6-gag |
Species | Human |
Expression System | HEK293 |
Form | Liquid |
Formulation | Supplied as 0.22 um filtered solution in PBS (pH 7.4). |
Endotoxin | Less than 1 EU per ug by the LAL method. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | VLPs are formed by spontaneous interaction between one or more viral structural capsid proteins to form the final structure. VLPs are structurally and visually similar to live viruses but lack either a complete virus genome or lack the entire virus genome[1]. The envelop VLP control is pure viral protein particle structure without the displayed proteins, which can be used as control for the activity assay of the envelope VLP display proteins. |